Kiser JJ - Search Results

1

Lower Cumulative Antiretroviral Exposure in People Living With HIV and Diabetes Mellitus.

Mann SC, Morrow M, Coyle RP, Coleman SS, Saderup A, Zheng JH, Ellison L, Bushman LR, Kiser JJ, MaWhinney S, Anderson PL, Castillo-Mancilla JR. Mann SC, et al. Among authors: kiser jj. J Acquir Immune Defic Syndr. 2020 Dec 1;85(4):483-488. doi: 10.1097/QAI.0000000000002460. J Acquir Immune Defic Syndr. 2020. PMID: 33136749 Free PMC article.

2

Therapeutic drug monitoring: pharmacologic considerations for antiretroviral drugs.

Kiser JJ, Anderson PL, Gerber JG. Kiser JJ, et al. Curr HIV/AIDS Rep. 2005 Jun;2(2):61-7. doi: 10.1007/s11904-005-0020-8. Curr HIV/AIDS Rep. 2005. PMID: 16091250 Review.

3

6th International Workshop on Clinical Pharmacology of HIV Therapy.

Kiser JJ, Anderson PL, Kakuda TN. Kiser JJ, et al. Expert Opin Pharmacother. 2006 Feb;7(2):229-41. doi: 10.1517/14656566.7.2.229. Expert Opin Pharmacother. 2006. PMID: 16433587

4

Effects of esomeprazole on the pharmacokinetics of atazanavir and fosamprenavir in a patient with human immunodeficiency virus infection.

Kiser JJ, Lichtenstein KA, Anderson PL, Fletcher CV. Kiser JJ, et al. Pharmacotherapy. 2006 Apr;26(4):511-4. doi: 10.1592/phco.26.4.511. Pharmacotherapy. 2006. PMID: 16553510

5

Atazanavir-containing renal calculi in an HIV-infected patient.

Anderson PL, Lichtenstein KA, Gerig NE, Kiser JJ, Bushman LR. Anderson PL, et al. Among authors: kiser jj. AIDS. 2007 May 11;21(8):1060-2. doi: 10.1097/QAD.0b013e3280c56ae1. AIDS. 2007. PMID: 17457108 No abstract available.

6

Drug/Drug interaction between lopinavir/ritonavir and rosuvastatin in healthy volunteers.

Kiser JJ, Gerber JG, Predhomme JA, Wolfe P, Flynn DM, Hoody DW. Kiser JJ, et al. J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):570-8. doi: 10.1097/QAI.0b013e318160a542. J Acquir Immune Defic Syndr. 2008. PMID: 18176327

7

Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patients.

Kiser JJ, Aquilante CL, Anderson PL, King TM, Carten ML, Fletcher CV. Kiser JJ, et al. J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):298-303. doi: 10.1097/qai.0b013e31815e7478. J Acquir Immune Defic Syndr. 2008. PMID: 18398970 Clinical Trial.

8

Effect of antacids on the pharmacokinetics of raltegravir in human immunodeficiency virus-seronegative volunteers.

Kiser JJ, Bumpass JB, Meditz AL, Anderson PL, Bushman L, Ray M, Predhomme JA, Rower J, Mawhinney S, Brundage R. Kiser JJ, et al. Antimicrob Agents Chemother. 2010 Dec;54(12):4999-5003. doi: 10.1128/AAC.00636-10. Epub 2010 Oct 4. Antimicrob Agents Chemother. 2010. PMID: 20921313 Free PMC article. Clinical Trial.

9

Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection.

Anderson PL, Kiser JJ, Gardner EM, Rower JE, Meditz A, Grant RM. Anderson PL, et al. Among authors: kiser jj. J Antimicrob Chemother. 2011 Feb;66(2):240-50. doi: 10.1093/jac/dkq447. Epub 2010 Nov 30. J Antimicrob Chemother. 2011. PMID: 21118913 Free PMC article. Review.

10

Assessing the effectiveness of pharmacy-based adherence interventions on antiretroviral adherence in persons with HIV.

Henderson KC, Hindman J, Johnson SC, Valuck RJ, Kiser JJ. Henderson KC, et al. Among authors: kiser jj. AIDS Patient Care STDS. 2011 Apr;25(4):221-8. doi: 10.1089/apc.2010.0324. Epub 2011 Feb 16. AIDS Patient Care STDS. 2011. PMID: 21323566

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters